Mortgaging Your Womb

I recently participated in a conversation on HuffPo Live about whether fertility finance companies are preying on families desperate to have children. Watch the segment here.
Before patients can become savvy consumers of healthcare, they need information about their healthcare choices. Too often, such information is nearly impossible to get, especially when it requires doctors to give patients useful statistics about things like treatment side effects. Since publishing Critical Decisions this fall, I have received a number of emails from readers who…
Jennifer spends lots of time with dead things, dead humans actually. She works in a pathology lab. One night, she is asked to incinerate a fresh human cadaver, and she is struck that it would be a waste to throw away perfectly good meat. So, even though she is against killing and is a vegetarian for moral reasons, she…
Cinnamon. Buttered popcorn. Strawberry and banana. Yummy tastes and smells that have lingered in my TV room, after my teenage son and his friends finish vaping. E-cigarette companies like Juul are creating flavors designed to lure young customers, following a tradition established by their cigarette-manufacturing predecessors. For a while, the Trump administration appeared poised to…
Many people die in ways, and even in locations, that go against their preferences. They don’t want to be put on ventilators and, yet, spend their last days in intensive care units tethered to breathing machines. They don’t want cardiopulmonary resuscitation (CPR), and, yet, receive full-on “codes” when their hearts stop.
Much of this unwanted care could be avoided if patients (aka: “people”) discussed their treatment preferences with their clinicians.
Steven Johnson was a rising star at the NordicWear Company, even before that brutal winter of 2002. But then, thanks to a rebate program he instituted for their new line of snow pants, he rocketed up the corporate ladder. His plan was brilliant in its simplicity. Late in the previous winter, he ran a series…
Recently I received an email from someone I have never met, who asked me the following: “Could you refer me to any current study results on Arimidex (Anastrozole)? My oncologist is not helpful. My oncotype dx said I have 9% chance of recurrence and with Arimidex for 5 years that is reduced to 4.5 %….